Northsight Capital, Inc. announced the appointment of John B. Hollister as CEO. Mr. Hollister brings more than 25 years of commercial management and fundraising experience in related pharmaceutical, biotech and medical device fields including SmithKline Beecham and Amgen. Most recently, Hollister worked as the CEO and Director of NEMUS Bioscience.